Mometasona Generis (Mometasone Furoate Anhydrous)

Mometasone furoate, the active ingredient in Mometasona Generis, is a corticosteroid presented as a nasal spray for intranasal use. It reduces nasal inflammation and is indicated for the treatment of allergic rhinitis and nasal polyps in adults and adolescents, helping to relieve congestion, sneezing and nasal discharge.

GNH USA supplies Mometasona Generis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasona Generis is a nasal corticosteroid that acts on inflammatory pathways of the nasal mucosa. - Allergic rhinitis: reduces nasal inflammation and symptoms such as congestion, sneezing and itching. - Nasal polyps: decreases polyp size and improves nasal airflow. - Non‑allergic rhinitis: alleviates nasal congestion and discharge.

Common Side Effects: - Nasal irritation or burning sensation. - Epistaxis (nosebleeds). - Headache. - Sore throat or cough. - Altered taste or smell.

Serious or Rare Side Effects: - Fungal infection of the nasal passages. - Severe or persistent epistaxis. - Adrenal suppression with systemic effects. - Vision changes such as cataracts or glaucoma. - Anaphylactic or severe allergic reactions.

Before using Mometasona Generis, consider the following precautions: - Pregnancy: consult a healthcare professional before use. - Lactation: discuss potential risks with a physician. - Elderly patients: monitor for systemic glucocorticoid effects. - Active nasal infection: avoid use until infection resolves. - Concurrent nasal surgery: postpone administration until post‑operative healing. - Store at room temperature: keep in the original container, protect from moisture and light.

Mometasona Generis may interact with other medicines as follows.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase systemic exposure. - Systemic corticosteroids: risk of additive glucocorticoid effects. - Live vaccines: may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., itraconazole): may raise local drug levels. - Ritonavir or other protease inhibitors: potential increase in exposure. - St. John’s wort or other enzyme inducers: may reduce effectiveness.